ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,775, issued on Jan. 20, was assigned to SHIONOGI & Co. LTD. (Osaka, Japan).
"Heteroaromatic derivatives having serotonin receptor binding activity" was invented by Kenji Nakahara (Osaka, Japan), Kouki Fuchino (Osaka, Japan) and Kotaro Nagatani (Osaka, Japan).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are compounds having a serotonin 5-HT2A receptor inverse agonism, pharmaceutically acceptable salts thereof, and a composition comprising them,A composition comprising the compounds of Formula (I): or pharmaceutically acceptable salts thereof, wherein: R1 is substituted or unsubstituted aromatic heterocyclyl or the like; R2 is each independe...